Importance Use of valproate and certain other antiseizure medications (ASMs) in pregnancy
is associated with abnormal fetal brain development with potential long-term implications for …

Importance There is concern about neurodevelopmental outcomes associated with prenatal
exposure to valproate and other antiepileptic drugs (AEDs) among children of mothers with …

Importance Prenatal antiseizure medication (ASM) exposure has been associated with
adverse early neurodevelopment, but associations with a wider range of psychiatric end …

Importance To date, few attempts have been made to examine associations between
exposure to maternal epilepsy with or without antiepileptic drug (AED) therapy and …

Importance The association of fetal exposure to antiseizure medications (ASMs) with
outcomes in childhood are not well delineated. Objective To examine the association of fetal …

Objective We studied the potential impact of antiepileptic drugs (AED s) on fetal growth and
gestational age at birth. Methods In the Danish Medical Birth Registry, we identified all …

Importance Women with epilepsy frequently need antiseizure medication (ASM) to prevent
seizures in pregnancy. Risk of neurodevelopmental disorders after prenatal exposure to …

Purpose Our objective was to assess the adverse outcomes during pregnancy, as well as for
the fetus and neonates, in women with epilepsy, both with and without the use of antiseizure …

Most infants born to women with epilepsy are healthy, but there are increased risks related
to in utero antiepileptic drug (AED) exposure and seizures. Emerging data from pregnancy …

Background Maternal use of valproate during pregnancy has been associated with an
increased risk of neurodevelopmental disorders in children. Although most studies of other …